Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 2:02 PM
Ignite Modification Date:
2025-12-25 @ 12:47 PM
NCT ID:
NCT02799095
Group ID:
EG007
Title:
Part B, Dose Expansion, Melanoma: Nemvaleukin Alfa 6 mcg/kg
Description:
Participants with melanoma received nemvaleukin alfa 6 mcg/kg IV infusion administration daily from Days 1 to 5 in Cycle 1 (Cycle length = 14 days) and then in Cycle 2 and subsequent cycles (each Cycle length = 21 days) until disease progression or the participant met any discontinuation criteria.
Deaths Number Affected:
7
Deaths Number At Risk:
None
Serious Number Affected:
11
Serious Number At Risk:
47
Other Number Affected:
46
Other Number At Risk:
47
Study:
NCT02799095
Results Section:
NCT02799095
Adverse Events Module:
NCT02799095